Premaitha Share Discussion Threads

[twix386] 21/8/2016 12:20

brainspark,

so what was said, please?
anyone?

[brainspark1] 21/8/2016 10:43

NHS rollout of NIPT on BBC2 today at 10:20am

[hjb1] 19/8/2016 14:25

so why don't they come out with a statement to inform us then??
Anyhow, I'm more interested in Esperite interims next Tuesday.Tranquility has been upgraded, so we will see.I expect good sales for nipt.

[ewads] 19/8/2016 14:14

Amazing what rumours do!
Doesn't seem to be any substance in the speculative bids.

[fillipe] 19/8/2016 11:39

twix - yes, I see that now....a bit of misreading on my part.
Thanks for your kind correction.

f

[twix386] 19/8/2016 11:31

fillipe,

PG's tp remained at 24p.
FinnCap's tp is 20p

neither has changed recently.

[fillipe] 19/8/2016 10:59

No doubt mentioned earlier here, but I see that PanmGord 4-7-2016 have it as a BUY with an increased tp of 24p.

f

[downyr] 19/8/2016 09:56

Timojelly based on past performance there will need to be a sustained run of good new to get anywhere close to the 20s but we can hope that at last this may happen

[brainspark1] 19/8/2016 08:24

600k traded already in the first 20 mins.
Looking good

[timojelly] 19/8/2016 08:03

Might get back to the 20s on this

[hurricane.] 19/8/2016 07:39

No comment from either company gives this legs imo

[hurricane.] 19/8/2016 07:38

Interesting developments.
Well I was going to wait until sept to add. Hmmm

[brainspark1] 19/8/2016 07:18

Coupled with next Tuesday, Esperite release their interim results

hxxp://www.esperite.com/?page_id=5402#

All eyes on Tranquility sales

Busy next few days

[brainspark1] 19/8/2016 07:16

"The deal as described is expensive on paper, totaling around half of Thermo Fisher's current market capitalization. However, if the speculation of an all-stock bid is true, the financial burden on the acquirer would be greatly diminished. More of a concern for Thermo Fisher investors -- and a potential boon for Illumina stockholders -- is the possibility of the offer setting off a bidding war."

[brainspark1] 19/8/2016 07:10

hxxp://www.investopedia.com/stock-analysis/081816/illumina-closes-slightly-takeover-reports-ilmn-tmo.aspx

[timojelly] 19/8/2016 05:43

The both refused to comment

[brainspark1] 18/8/2016 22:52

As they say "No smoke without fire."

[hjb1] 18/8/2016 21:34

analysts view!
then again wtfdtk! it's probably going to happen then.lol

Analysts Pour Cold Water on Rumor of Thermo Fisher Making Acquisition Bid for Illumina

Aug 18, 2016 | a GenomeWeb staff reporter
.






NEW YORK (GenomeWeb) – Following a report on Seeking Alpha that Thermo Fisher Scientific had made a $30 billion offer to acquire Illumina, a number of analysts said today that such a deal would be unlikely.

Both Thermo Fisher and Illumina declined to comment on the speculation.

In a research note, Cowen and Company analyst Doug Schenkel noted that such a deal would be "highly unlikely" for several reasons. The $30 billion offer would be less than a 20 percent premium to Illumina's stock price; a merger would raise antitrust issues; and such a deal would be difficult for Thermo Fisher to justify financially, Schenkel wrote.

Tim Evans, senior analyst with Wells Fargo, agreed that a deal would "encounter significant regulatory hurdles given that [Illumina] holds a near monopoly in high-throughput sequencing, and [Thermo Fisher] is the only current competitor with material scale in desktop sequencing."

Bryan Brokmeier, an analyst at Cantor Fitzgerald, added that Illumina would be unlikely to sell. Francis deSouza just took the reins as CEO of Illumina in July, he noted, and it would be surprising if he sold so quickly. In addition, he said, there is likely an "inflection point" in the clinical market that Illumina will recognize and that "isn't fully valued into the stock."

Thermo Fisher, meantime, would also be unlikely to want to acquire Illumina, Brokmeier wrote. Not only does the company have its own sequencing business, but it also recently acquired Affymetrix for $1.3 billion and is in the middle of a $4.2 billion acquisition of the microscope company, FEI Company.

Brokmeier noted that if Thermo Fisher does make an offer for Illumina, it could spur renewed interest in Pacific Biosciences by potential acquirers other than Roche, which has a partnership with PacBio, including PerkinElmer and Agilent Technologies.

[timojelly] 18/8/2016 19:13

Juicy news. A long way to go though. It's like Boeing making a hostile bid for Airbus. We'll see. Can only help the shareprice though.

[the monkster] 18/8/2016 18:56

Down 0.375 would be my guess

[hjb1] 18/8/2016 18:50

Brain, ha ha! wishful thinking eh?

[brainspark1] 18/8/2016 17:45

Excellent news. Roll on tomorrow

Be quick, can see these being 15p+ in the first 10 minutes of trading

[hjb1] 18/8/2016 17:31

great news if there is indeed a buyout by TF...litigation problem solved..

[hjb1] 18/8/2016 17:08

Esperite have upgraded tranquillity...so sales are booming !!

[hjb1] 18/8/2016 17:06

interesting!!